Publication | Closed Access

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials

AsthmaMedicineDual Pde3Healthy VolunteersClinical TrialsPde4 InhibitorPulmonary PharmacologyPulmonary MedicinePharmacotherapyPharmacologyPulmonary Disease